RECENT SUCCESSES
Over the years, Farmacon Global’s success has been a testament to our steadfast commitment to excellence, specifically in navigating the intricacies of clinical research. Our focus areas include Immunology, Rare and Infectious Diseases, Cancer, and the emerging market of Latin America.
Past & Current Sponsors
Farmacon Global’s Recent Successes in Rare Diseases:
- Accelerated enrollment for a Rare Kidney Disease project in Brazil and Argentina by enrolling the largest number of patients, saving six months of start-up time.
- Provided 80% of patients for a Rare Liver Disease project, facilitating the genetic testing and educational outreach with Key Opinion Leaders (KOLs) / Principal Investigators (PIs), leading to expedited regulatory timelines in Brazil.
- Contributed 20% of patients for a Global Ultra Rare Disease project from Brazil, Mexico, Argentina, and Colombia, collaborating seamlessly with a Global CRO.
- Maintained a 100% patient retention rate in a Phase 3 trial for Hunter’s disease, a significant achievement for a major Pharma in Mexico.
- Conducted several Good Clinical Practice (GCP) and FDA Preparation Audits across Latin America, coupled with providing crucial medical monitoring.
Farmacon Global’s Recent Successes in COVID-19 and Vaccines:
- Overcame enrollment challenges during the COVID-19 pandemic by validating and engaging key KOLs and 32 sites in five countries, contributing 19,000 patients for a Phase III COVID-19 vaccine trial in Latin America.
- Successfully launched Farmacon Academy, educating KOLs who are pediatric neurologists about the value and in-depth knowledge of clinical research to enhance their capabilities for quality research.